Beta Bionics, Inc. (NASDAQ:BBNX) Q4 2025 Earnings Call Transcript February 18, 2026 Operator: Good day, and thank you for standing by. Welcome to the Beta Bionics Inc. Q4 and Full Year 2025 Earnings ...
The outlook for drug development to treat rare diseases looks encouraging, offering hope to the 300 million people globally facing the significant challenges of these often-overlooked conditions.
Delirium is a sudden change in thinking that makes someone confused and disoriented. It is common among older adults in hospitals and is usually temporary. Risk factors for delirium include age, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results